![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SCOLR PHARMA ENTERS RESEARCH COLLABORATION TO CO-DEVELOP NOVEL FLU APPLICATION
SCOLR PHARMA ENTERS RESEARCH COLLABORATION TO CO-DEVELOP NOVEL FLU APPLICATION
SCOLR Pharma, Inc. announced that it has entered into a research collaboration with a US-based biopharmaceutical company to develop an oral formulation of a promising antiviral compound using SCOLR's proprietary CDT drug delivery platform. The compound under development has the potential to be used as a treatment against influenza. The goal of the program is to enhance the bioavailability of our partner's compound to facilitate oral administration. If successful, the parties expect to enter a license agreement which would provide for the potential commercialization of a significant new pharmaceutical product.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct